Aki Murakami

643 total citations
23 papers, 491 citations indexed

About

Aki Murakami is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Aki Murakami has authored 23 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Aki Murakami's work include Occupational and environmental lung diseases (6 papers), Pleural and Pulmonary Diseases (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Aki Murakami is often cited by papers focused on Occupational and environmental lung diseases (6 papers), Pleural and Pulmonary Diseases (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Aki Murakami collaborates with scholars based in Japan, Australia and United States. Aki Murakami's co-authors include Takashi Nakano, Shusai Yamada, Tohru Sugimoto, Kazuya Fukuoka, Akira Nishimura, Kei Yamada, Tsunehiko Nishimura, Masafumi Morimoto, Chiharu Tabata and Yoshie Yoshikawa and has published in prestigious journals such as PLoS ONE, PEDIATRICS and European Respiratory Journal.

In The Last Decade

Aki Murakami

21 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aki Murakami Japan 11 217 120 99 98 89 23 491
Kathleen Kelley United States 7 85 0.4× 51 0.4× 96 1.0× 76 0.8× 28 0.3× 12 382
Marios Kaliakatsos United Kingdom 12 53 0.2× 51 0.4× 114 1.2× 83 0.8× 5 0.1× 31 411
Baoqin Gao China 17 48 0.2× 87 0.7× 106 1.1× 120 1.2× 9 0.1× 28 426
S. Martha Meyer United States 12 41 0.2× 43 0.4× 34 0.3× 87 0.9× 97 1.1× 21 623
Lan Xu China 14 40 0.2× 56 0.5× 60 0.6× 107 1.1× 10 0.1× 22 304
A. Hotze Germany 13 52 0.2× 12 0.1× 61 0.6× 26 0.3× 110 1.2× 40 371
A. Bowden United Kingdom 9 52 0.2× 68 0.6× 41 0.4× 66 0.7× 18 0.2× 18 486
P D Ottosen Denmark 8 286 1.3× 32 0.3× 75 0.8× 427 4.4× 7 0.1× 9 589
Yoshiko Hirano Japan 12 49 0.2× 43 0.4× 83 0.8× 143 1.5× 7 0.1× 27 430
C. Li China 10 76 0.4× 39 0.3× 10 0.1× 87 0.9× 29 0.3× 13 394

Countries citing papers authored by Aki Murakami

Since Specialization
Citations

This map shows the geographic impact of Aki Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aki Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aki Murakami more than expected).

Fields of papers citing papers by Aki Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aki Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aki Murakami. The network helps show where Aki Murakami may publish in the future.

Co-authorship network of co-authors of Aki Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Aki Murakami. A scholar is included among the top collaborators of Aki Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aki Murakami. Aki Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takeda, Daisuke, Hotaka Kawai, Aki Murakami, et al.. (2024). Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma. PLoS ONE. 19(4). e0302194–e0302194. 1 indexed citations
3.
4.
Takeda, Daisuke, Aki Murakami, Izumi Saito, et al.. (2023). Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model. PLoS ONE. 18(8). e0290357–e0290357. 1 indexed citations
5.
Hasegawa, Takumi, Daisuke Takeda, Aki Murakami, et al.. (2021). Local Application of Transcutaneous Carbon Dioxide Paste Decreases Inflammation and Accelerates Wound Healing. Cureus. 13(11). e19518–e19518. 5 indexed citations
6.
7.
Kuribayashi, Kozo, Shigeru Miyata, Kazuya Fukuoka, et al.. (2013). Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma. Molecular and Clinical Oncology. 1(4). 639–642. 7 indexed citations
8.
Yoshikawa, Yoshie, Ayuko Sato, Tohru Tsujimura, et al.. (2012). Frequent inactivation of the BAP1 gene in epithelioid‐type malignant mesothelioma. Cancer Science. 103(5). 868–874. 137 indexed citations
9.
Murakami, Aki, Yoshihiro Fujimori, Yoshie Yoshikawa, et al.. (2012). Heme Oxygenase-1 Promoter Polymorphism is Associated with Risk of Malignant Mesothelioma. Lung. 190(3). 333–337. 16 indexed citations
10.
Murakami, Aki, et al.. (2011). Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma. Oncology Letters. 3(3). 581–585. 5 indexed citations
11.
Tabata, Chiharu, Rie Tabata, Noriko Hirayama, et al.. (2010). Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 5(4). 479–483. 61 indexed citations
12.
Tabata, Chiharu, Rie Tabata, Shusai Yamada, et al.. (2010). A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma. European Respiratory Journal. 36(5). 1099–1105. 13 indexed citations
13.
Hasegawa, Tatsuji, Kei Yamada, Masafumi Morimoto, et al.. (2010). Development of Corpus Callosum in Preterm Infants Is Affected by the Prematurity: In Vivo Assessment of Diffusion Tensor Imaging at Term-Equivalent Age. Pediatric Research. 69(3). 249–254. 51 indexed citations
14.
Tabata, Chiharu, Rie Tabata, Shusai Yamada, et al.. (2009). All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice. European Respiratory Journal. 34(5). 1159–1167. 15 indexed citations
15.
Morimoto, Masafumi, Emi Mazaki, Akira Nishimura, et al.. (2006). SCN1AMutation Mosaicism in a Family with Severe Myoclonic Epilepsy in Infancy. Epilepsia. 47(10). 1732–1736. 53 indexed citations
16.
Imamura, Toshihiko, Akira Morimoto, Ryuichi Kato, et al.. (2005). Cerebral thrombotic complications in adolescent leukemia/lymphoma patients treated with L-asparaginase-containing chemotherapy. Leukemia & lymphoma. 46(5). 729–735. 13 indexed citations
17.
Murakami, Aki, et al.. (2005). Infantile bilateral striatal necrosis associated with human herpes virus-6 (HHV-6) infection. Brain and Development. 27(7). 527–530. 13 indexed citations
18.
Ohashi, Hirokazu, et al.. (1994). [Comparison of long-term clinical results and cost-effectiveness of percutaneous coronary angioplasty and coronary artery bypass grafting].. PubMed. 42(2). 222–7. 3 indexed citations
19.
Goto, Jun, et al.. (1993). Effect of ON-579, a novel TXA2 antagonist, on platelet aggregation in vitro and in vivo.. The Japanese Journal of Pharmacology. 61. 207–207. 1 indexed citations
20.
Kumagai, Hiroshi, et al.. (1991). Effect of aging, castration, and testosterone administration on ribonuclease an ribonuclease-inhibitor activities in the prostate of rats.. Chemical and Pharmaceutical Bulletin. 39(1). 137–141. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Kelley Breakdown of academic impact, for papers by Marios Kaliakatsos Breakdown of academic impact, for papers by Baoqin Gao Breakdown of academic impact, for papers by S. Martha Meyer Breakdown of academic impact, for papers by Lan Xu Breakdown of academic impact, for papers by A. Hotze Breakdown of academic impact, for papers by A. Bowden Breakdown of academic impact, for papers by P D Ottosen Breakdown of academic impact, for papers by Yoshiko Hirano Breakdown of academic impact, for papers by C. Li
Rankless by CCL
2026